Market Place
Sourcing Support
Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial
01 Apr 2025 //
GLOBENEWSWIRE
Sernova Appoints Pericles Calias As Chief Development Officer
10 Mar 2025 //
GLOBENEWSWIRE
Sernova Biotherapeutics Secures $1 M Convertible Debt Financing
05 Mar 2025 //
GLOBENEWSWIRE
Sernova Gets FDA IND Clearance For Cell Pouch Bio-Hybrid Organ
03 Mar 2025 //
GLOBENEWSWIRE
Sernova Submits IND for Bio-Hybrid Organ in Hypothyroidism
03 Feb 2025 //
GLOBENEWSWIRE
Sernova Announces Appointment of Ross as Chair of Board
30 Jan 2025 //
GLOBENEWSWIRE
Sernova Reports Voting Results From Annual General Meeting
13 Jan 2025 //
GLOBENEWSWIRE
Sernova Reschedules AGM and Special Meeting to Jan 10, 2025
20 Dec 2024 //
GLOBENEWSWIRE
Sernova Reports Positive Data From Islet Survival And Function Trial
12 Sep 2024 //
GLOBENEWSWIRE
Sernova Corp. Announces Appointment of New Chief Executive Officer
12 Aug 2024 //
GLOBENEWSWIRE
Sernova Announces Advancements of Conformal Coating with Cell Pouch System
30 Oct 2023 //
GLOBENEWSWIRE
Sernova Announces Positive Interim Phase 1/2 Data for the Cell Pouch System
27 Oct 2023 //
GLOBENEWSWIRE
Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA
11 Oct 2023 //
GLOBENEWSWIRE
Sernova Presents Compelling Data on Cell Pouch System as a Promising Treatment
29 Sep 2023 //
GLOBENEWSWIRE
Sernova Investor Conference Call Now Rescheduled for September 22
14 Sep 2023 //
GLOBENEWSWIRE
Sernova Provides Update on Proprietary Cellular Conformal Coating Technology
07 Sep 2023 //
GLOBENEWSWIRE
Sernova Appointed Modestus Obochi, Ph.D., MBA, as Chief Business Officer
26 Jul 2023 //
GLOBENEWSWIRE
Sernova Announces Positive Updated Phase 1/2 Data for the Cell Pouch System
26 Jun 2023 //
GLOBENEWSWIRE
Sernova says five diabetes patients have now been taken off insulin
26 Jun 2023 //
ENDPTS
Sernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System
22 Jun 2023 //
GLOBENEWSWIRE
Sernova Announces Executive Alignment and Appoints New Board Chair
31 May 2023 //
GLOBENEWSWIRE
Sernova Announces Research Collaboration with AstraZeneca
03 May 2023 //
GLOBENEWSWIRE
Results Using Sernova`s Cell Pouch System with Evotec`s Islet-like Clusters
24 Apr 2023 //
GLOBENEWSWIRE
Two Independent Proxy Advisory Firms, Including Glass Lewis & Co. LLC
18 Apr 2023 //
GLOBENEWSWIRE
Sernova to Present at Alliance for Regenerative Medicine Cell & Gene Meeting
10 Apr 2023 //
GLOBENEWSWIRE
Sernova Responds to Dissident Shareholders Misleading Statements
06 Apr 2023 //
GLOBENEWSWIRE
Sernova responds to board nominees from `concerned shareholders`
06 Apr 2023 //
ENDPTS
Sernova Announces Abstract on First Cohort of its Phase 1/2 Study Involving Islet Allotransplantation
22 Mar 2023 //
GLOBENEWSWIRE
Sernova Announces Presentation of iPSC and Cell Pouch Combination Treatment
14 Mar 2023 //
GLOBENEWSWIRE
Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled
08 Mar 2023 //
GLOBENEWSWIRE
Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences
02 Mar 2023 //
GLOBENEWSWIRE
Sernova Announces Advancements with Cell Pouch to Preserve Thyroid Function
30 Jan 2023 //
GLOBENEWSWIRE
Sernova and Evotec on Track to Initiate Clinical Testing of iPSC-Derived Islets
10 Jan 2023 //
GLOBENEWSWIRE
Sernova Announces First Two Patients Implanted with Cell Pouch™
17 Nov 2022 //
GLOBENEWSWIRE
Sernova got Authorization to Enroll 2nd Patient in Ph 1/2 Trial with Cell Pouch
03 Nov 2022 //
GLOBENEWSWIRE
Sernova to Participate in the Roth Inaugural Healthcare Opportunities Conference
28 Sep 2022 //
GLOBENEWSWIRE
Sernova Announces Full Exercise of Share Purchase Warrants Expiring
22 Sep 2022 //
GLOBENEWSWIRE
